News
SCNI
0.2510
-1.57%
-0.0040
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 4d ago
Weekly Report: what happened at SCNI last week (0615-0619)?
Weekly Report · 4d ago
Scinai Immunotherapeutics Shareholders Approve Board Slate, Equity Expansion and Executive Awards
TipRanks · 06/17 10:31
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 06/15 21:05
Scinai Immunotherapeutics Boosts CDMO Platform With Recipharm Israel Deal and Q1 2026 Turn to Profit
TipRanks · 06/15 11:17
Weekly Report: what happened at SCNI last week (0608-0612)?
Weekly Report · 06/15 09:07
Scinai Immunotherapeutics reports Q1 results
Seeking Alpha · 06/10 20:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 06/09 21:06
Scinai Immunotherapeutics Clarifies Chairman Service Agreement Ahead of June 16 AGM
TipRanks · 06/08 17:19
Weekly Report: what happened at SCNI last week (0601-0605)?
Weekly Report · 06/08 09:06
Weekly Report: what happened at SCNI last week (0525-0529)?
Weekly Report · 06/01 09:07
Weekly Report: what happened at SCNI last week (0518-0522)?
Weekly Report · 05/25 09:07
Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility
PR Newswire · 05/20 11:00
Weekly Report: what happened at SCNI last week (0511-0515)?
Weekly Report · 05/18 09:07
Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe
PR Newswire · 05/15 12:05
Scinai Immunotherapeutics Sets June 16, 2026 Shareholder Meeting to Expand Share Capital and Approve Executive Incentives
TipRanks · 05/12 22:46
Weekly Report: what happened at SCNI last week (0504-0508)?
Weekly Report · 05/11 09:07
Scinai files to sell 16.34M American Depositary shares for holders
TipRanks · 05/08 23:02
Scinai Immunotherapeutics Files Pro Forma Financials After February Acquisition of Recipharm Israel
TipRanks · 05/08 11:57
Weekly Report: what happened at SCNI last week (0427-0501)?
Weekly Report · 05/04 09:06
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.